Literature DB >> 3820512

Colchicine in acute gout. Reassessment of risks and benefits.

W N Roberts, M H Liang, S H Stern.   

Abstract

Colchicine is an effective and relatively specific treatment for acute gout and has a long, venerable history. Serious toxic reactions to colchicine could be prevented if guidelines for its use were followed strictly, but because of its relatively infrequent use and conflicting recommendations, considerable toxic effects might occur and still be undetected by passive surveillance. A review of a teaching hospital's four years' experience showed two deaths (2% incidence) due to inappropriate use. Colchicine has the smallest benefit-to-toxicity ratio of drugs that are effective for acute gout. This article gives specific recommendations for the use of colchicine in different clinical settings.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3820512

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  18 in total

Review 1.  Colchicine--expanding horizons.

Authors:  A Schattner
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

Review 2.  Crystal-associated rheumatic disease. Current management considerations.

Authors:  E Arie; M Doherty
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

3.  Defining 'surveillance' in drug safety.

Authors:  Jeffrey K Aronson; Manfred Hauben; Andrew Bate
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

4.  Improved growth and colchicine concentration in Gloriosa superba on mycorrhizal inoculation supplemented with phosphorus-fertilizer.

Authors:  Devendra Kumar Pandey; Tabarak Malik; Abhijit Dey; Joginder Singh; R M Banik
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-01-28

5.  Reversal of colchicine-induced mitotic arrest in Chinese hamster cells with a colchicine-specific monoclonal antibody.

Authors:  S K Rouan; I G Otterness; A C Cunningham; H E Holden; C T Rhodes
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

6.  Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.

Authors:  M Rochdi; A Sabouraud; C Girre; R Venet; J M Scherrmann
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 7.  Pathophysiology, clinical presentation and treatment of gout.

Authors:  Gim Gee Teng; Raj Nair; Kenneth G Saag
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 8.  Update on colchicine and its mechanism of action.

Authors:  Yair Molad
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

Review 9.  Prevention and management of gout.

Authors:  V L Star; M C Hochberg
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

10.  Colchicine in acute gout: low dose colchicine was started after usual dose.

Authors:  G Sivagnanam
Journal:  BMJ       Date:  2004-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.